Thursday May 23, 2019 Change -3.27% Price $5.91
Chart period: 2019-02-25 - 2019-05-23




Will VRNA stock price go up or down on Tue, 28 May 2019?


Verona Pharma plc Forecast and Stock Analysis

Technical VRNA stock analysis for Thursday May 23, 2019.

Sell candidate since 2019-05-09 Loss -6.19%
Shorts n/a
Insider % n/a
Institutional % 54.80%
Beta 0.40
ROA -13.61%
Price to book USD 1.06
P/E Ratio -5.96
Next Earnings Date 2019-09-10

Verona Pharma plc fell by -3.27% in the last day ( Thursday, 23rd May 2019 ) from $6.11 to $5.91 and has now fallen 3 days in a row. During day the stock fluctuated 5.93% from a day low at $5.90 to a day high of $6.25. The price has been going up and down for this period, and there has been a -6.19% loss for the last 2 weeks. Volume has increased in the last day by 3 217 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 4 244 shares bought and sold for approximately $25 082.00.

Quick summary:

  • 30 day high of the VRNA stock price was $6.70 and low was $5.80.
  • 90 day high was $6.93 and low was $5.52.
  • 52 week high for the Verona Pharma plc - $17.16 and low - $5.52.


Verona Pharma plc lies in the lower part of a wide and weak rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $5.79 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 3.97% during the next 3 months and, with 90% probability hold a price between $6.01 and $7.35 at the end of this period.

Click here for today's Top 5 Trending Companies


There are few to none technical positive signals at the moment. Verona Pharma plc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $6.03 and $6.29. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday May 21, 2019, which indicates further falls until a new bottom pivot has been found. Verona Pharma plc gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's". The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

A sell signal from a double bottom formation was found on Tuesday May 21, 2019 with a target of $5.96. Despite the objective of the signal formation has been reached the stock may continue to fall.

Relative Strength Index (RSI)

RSI14 is 35 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Verona Pharma plc finds support from accumulated volume at $5.81.

Support: $5.81 Price: $5.91 Resistance: $6.06


This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.35 (5.93%) between high and low. For the last week, the stock has had a daily average volatility of 3.50%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

3.50 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

VRNA $5.91 ($-0.20 -3.27%)
VRNA is down $0.20 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for VRNA based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for readers.

Click here – the VRNA analysis is free »

Will VRNA stock price go up or down
on Tue, 28 May 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank